ktd Kocatepe Tıp Dergisi 3061-9904 Afyonkarahisar Sağlık Bilimleri Üniversitesi Kavernöz Hemanjiom Tedavisi Sonrası Cushing Sendromu Gelişen Olguda Geçici Hipertansiyon Kavernöz Hemanjiom Tedavisi Sonrası Cushing Sendromu Gelişen Olguda Geçici Hipertansiyon Şen Tolga Altuğ Melek Hamide Köken Reşit Adnan Narci 08 01 2007 8 2 41 43 05 08 2015 Copyright © 1999, Kocatepe Tıp Dergisi 1999 Kocatepe Tıp Dergisi

Kortikosteroidler değişik hastalıkların tedavisinde yaygın olarak kullanılmaktadır. Kullanımları sırasında bazı hastalarda geri dönüşümlü hipotalamo-pituiter-adrenal yolunun baskılanmasına neden olabilmektedirler. Sağ göz kapağının üzerindeki kavernöz hemanjiom nedeniyle iki ay boyunca farmakolojik dozda topikal kortikosteroid kullanımı sonucu Cushing sendromu gelişen 9 aylık kız hasta sunulmuştur

 Cushing sendromu oral kortikosteroid kavernöz hemanjiom hipertansiyon - Kandemir N. Adrenal Hastalıklar. Günöz H, Öcal G, Yordam N, Kurtoğlu S (Editörler). Pediatrik Endok- rinoloji, Pediatrik Endokrinoloji ve Oksoloji Derneği Yayınları: 1, pp: 361-414. Miller WL. The adrenal cortex and its disorders. In: Brook CGD, Hindmarsh PC, eds. Clinical pediatric endocrinology, 4th ed. Oxford: Blackwell Science, 2001:321–76. Root AW, Shulman DI. Clinical Adrenal Disorders. In: Pescovitz OH, Eugster EA, editors, Pediatric Endocrinology. Philadelphia: Lippincott Willams and Wilkins 2004. pp: 568-600. Abma EM, Blanken R, De Heide LJ. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med. 2002; 60: 148-50. Halverstam CP, Vachharajani A, Mallory SB. Cushing syndrome from percutaneous absorption of 1% hydrocortisone oinment in Netherton syndrome. Pediatr Dermatol 2007; 24: 42-5. Sıklar Z, Bostanci I, Atlı O, Dallar Y. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol. 2004; 21: 561-3. Ermiş B, Ors R, Tastekin A, Ozkan B. Cushing's syndrome secondary to topical corticosteroids abuse. Clin Endocrinol. 2003; 58: 795-6. Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pulmonol 2002; 33: 208–20. Perry RJ, Findlay CA, Donaldson MDC. Cushing’s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child. 2002; 87 :45–8. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000; 130: 240–1. Teelucksingh S, Balkaran B, Ganeshmoorthi A, Arthur P. Prolonged childhood Cushing’s syndrome secondary to intralesional triamcinolone acetonide. Ann Trop Paediatr. 2002; 22: 89–91. Steelman J, Kappy M. Adrenal suppression and growth retardation from ocular corticosteroids. J Pe- diatr Ophthalmol Strabismus. 2001; 38: 177–8. Bernstein D. Evaluation of the cardiac system. In: Nelson Textbook of Pediatrics Kleigman RM, Behrman RE (eds). 2007, pp:1861-2. Mafee MF, Atlas SW, Galetta SL. Eye, orbit; and visual system. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2002; pp: 1480-4. Haik BG, Karcioğlu ZA, Gordon RA, Pechous BP. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmology 1994; 38: 399- 426. Gunalp I, Gunduz K. Vascular tumors of the orbit. Doc Ophthalmol 1995; 89: 337-45. Wróblewska E, Toczołowski J. Treatment of eyelid hemangioma in children with intralesional steroid injection. Klin Oczna. 2001; 103: 229-31. Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak. 2006; 16: 662-5. Migeon CJ. Adrenal cortex. In: Lifshitz F (ed). Pediatric Endocrinology (3rd ed., revised and expanded). New York: Markel Dekker, Inc, 2003: 147-74. Hendrikse JC, Molenaar AJ. Adrenal and pituitary function during long-term topical steroid therapy. Dermatologica 1972; 144:179-180. Hogan DJ, Sibley JT, Lane PR. Avascular necrosis of the hips following long-term use of clobetasole propionate. J Am Acad Dermatol 1986; 14: 515-7. Katsushima H, Souma K, Nishio C. Glaucoma and posterior subcapsular cataract after long-term use of corticosteroid lotion in case with photodermatitis. Jpn J Clin Ophthalmol 1986; 40: 1345-9. Seth A, Aggarwal Anu. Monitoring adverse reactions to steroid therapy in children. Indian Pediatrics 2004; 4: 349-57. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: Factors affecting the risk of systemic adverse effects. Pharmacol Therapy. 1999; 83: 153- 79. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, et al. Cushing’s syndrome in children and adolescents. Presentation, diagnosis and therapy. New Eng J Med 1994; 331: 629-39. Chamberlin P, Meyer WJ. Management of pituiary- adrenal suppression secondary to corticosteroid therapy. Pediatrics 1981; 67: 245-51. Byyney RL. Withdrawal from glucocorticoid therapy. N Engl J Med 1976; 295: 30-2.